On Wednesday, June 29, 2022, from 12:05 p.m.-1:00 p.m. ET, the U.S. Food and Drug Administration (FDA) will host the next virtual Town Hall for SARS-CoV-2 test developers. During this Town Hall, the FDA will answer technical questions about the development and validation of tests for SARS-CoV-2.

Panelists include:

• Timothy Stenzel, M.D., Ph.D., Director of the Office of In Vitro Diagnostics
• Toby Lowe, Associate Director for Regulatory Programs, Office of In Vitro Diagnostics
• Kristian Roth, Ph.D., Deputy Director of the Division of Microbiology Devices, Office of In Vitro Diagnostics

There will be an opportunity to ask questions live on the call, but questions may also be submitted in advance by emailing CDRHWebinars@fda.hhs.gov.

• Submit questions by Monday, June 27, 2022, by 12 p.m. ET.
• In the subject line of the email, state “Question for the COVID-19 Test Virtual Town Hall”